White House Targets Prescription Drug Costs, Eyes PBM Reform with Industry Leaders

[cafead]

via In the heart of Washington D.C., a pivotal moment unfolds as the White House gears up to host a listening session that could mark the beginning of a new era in healthcare affordability. This Monday, key players from the federal government, the healthcare industry, and advocacy groups will come together to tackle one of the most pressing issues facing Americans today: the soaring costs of prescription drugs. At the center of this discussion are the pharmacy benefit managers (PBMs), the behind-the-scenes operators in drug pricing that have long been shrouded in controversy over their role in escalating healthcare expenses.

article source